Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis.
Zoref-Lorenz A, Murakami J, Hofstetter L, Iyer S, Alotaibi AS, Mohamed SF, Miller PG, Guber E, Weinstein S, Yacobovich J, Nikiforow S, Ebert BL, Lane A, Pasvolsky O, Raanani P, Nagler A, Berliner N, Daver N, Ellis M, Jordan MB. Zoref-Lorenz A, et al. Among authors: daver n. Blood. 2022 Feb 17;139(7):1098-1110. doi: 10.1182/blood.2021012764. Blood. 2022. PMID: 34780598 Free PMC article.
Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes.
Tamamyan GN, Kantarjian HM, Ning J, Jain P, Sasaki K, McClain KL, Allen CE, Pierce SA, Cortes JE, Ravandi F, Konopleva MY, Garcia-Manero G, Benton CB, Chihara D, Rytting ME, Wang S, Abdelall W, Konoplev SN, Daver NG. Tamamyan GN, et al. Among authors: daver ng. Cancer. 2016 Sep 15;122(18):2857-66. doi: 10.1002/cncr.30084. Epub 2016 May 31. Cancer. 2016. PMID: 27244347 Free PMC article.
Enhancing cytotoxicity of immunotoxins in AML.
Daver N, Ravandi F. Daver N, et al. Blood. 2016 Jun 9;127(23):2787-8. doi: 10.1182/blood-2016-04-708214. Blood. 2016. PMID: 27282944 Free article. No abstract available.
More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia.
Montalban-Bravo G, Benton CB, Wang SA, Ravandi F, Kadia T, Cortes J, Daver N, Takahashi K, DiNardo C, Jabbour E, Borthakur G, Konopleva M, Pierce S, Bueso-Ramos C, Patel K, Kornblau S, Kantarjian H, Young KH, Garcia-Manero G, Andreeff M. Montalban-Bravo G, et al. Among authors: daver n. Blood. 2017 May 4;129(18):2584-2587. doi: 10.1182/blood-2016-11-749903. Epub 2017 Feb 28. Blood. 2017. PMID: 28246192 Free PMC article. Clinical Trial. No abstract available.
Diagnostic Challenges of Hemophagocytic Lymphohistiocytosis.
Otrock ZK, Daver N, Kantarjian HM, Eby CS. Otrock ZK, et al. Among authors: daver n. Clin Lymphoma Myeloma Leuk. 2017 Jul;17S:S105-S110. doi: 10.1016/j.clml.2017.02.017. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28760295 Review.
PET-CT in AML-related hemophagocytic lymphohistiocytosis.
Boddu P, Oviedo SP, Rausch CR, Yam C, Daver N, Kantarjian H, Kadia TM. Boddu P, et al. Among authors: daver n. Leuk Lymphoma. 2018 Jun;59(6):1486-1489. doi: 10.1080/10428194.2017.1379079. Epub 2017 Sep 28. Leuk Lymphoma. 2018. PMID: 28958191 No abstract available.
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis.
Masarova L, Verstovsek S, Hidalgo-Lopez JE, Pemmaraju N, Bose P, Estrov Z, Jabbour EJ, Ravandi-Kashani F, Takahashi K, Cortes JE, Ning J, Ohanian M, Alvarado Y, Zhou L, Pierce S, Gergis R, Patel KP, Luthra R, Kadia TM, DiNardo CD, Borthakur G, Bhalla K, Garcia-Manero G, Bueso-Ramos CE, Kantarjian HM, Daver N. Masarova L, et al. Among authors: daver n. Blood. 2018 Oct 18;132(16):1664-1674. doi: 10.1182/blood-2018-04-846626. Epub 2018 Sep 5. Blood. 2018. PMID: 30185431 Free PMC article. Clinical Trial.
485 results